Medicare Enrolled
Dr. Sunir Garg, M.D.
Ophthalmology · Plymouth Meeting, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Garg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garg?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Garg
Dr. Sunir Garg is an ophthalmology specialist in Plymouth Meeting, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Garg performed 51,663 Medicare services across 6,021 unique beneficiaries.
Between the years covered by Open Payments, Dr. Garg received a total of $203,408 from 25 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Garg is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 1% volume in PA
$203,408 industry payments
Medicare Practice Summary
Medicare Utilization ↗51,663
Medicare services
Top 1% in PA for ophthalmology
6,021
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,460 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
23,160 | $29 | $73 |
| Injection, ranibizumab, 0.1 mg | 6,889 | $189 | $900 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
4,943 | $30 | $145 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
4,812 | $217 | $800 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
3,303 | $101 | $498 |
| Aflibercept eye injection (Eylea) | 2,696 | $689 | $2,433 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
2,098 | $70 | $195 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
1,310 | $72 | $275 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
690 | $120 | $466 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
453 | $1 | $4 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
287 | $158 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
262 | $117 | $355 |
| Extended eye exam with retinal drawing A detailed examination of the back of the eye that includes creating a drawing of the retina. |
156 | $18 | $85 |
| Injection into eye membrane A procedure involving the injection of a drug or substance into the membrane that covers the eyeball. |
110 | $39 | $329 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
92 | $81 | $487 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
73 | $106 | $435 |
| Ultrasound of eye tissue and structures A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures. |
49 | $37 | $215 |
| Retinal membrane and internal limiting membrane removal A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina. |
48 | $926 | $6,125 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
35 | $1,821 | $7,058 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
34 | $26 | $215 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $66 | $235 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
30 | $105 | $330 |
| Complex detached retina repair with eye fluid drainage A surgical procedure to repair a detached retina and drain fluid located between the lens and the retina. |
21 | $1,076 | $7,425 |
| Laser vitreolysis A laser procedure used to destroy fluid in the vitreous of the eye, located between the lens and the retina. |
19 | $736 | $5,395 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
19 | $20 | $85 |
| Retinal detachment repair with fluid drainage A surgical procedure to reattach a detached retina by draining excess fluid from the space between the lens and the retina. |
15 | $973 | $6,835 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $54 | $160 |
| Retinal photocoagulation to prevent detachment This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye. |
13 | $185 | $2,230 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$203,408
Total received (2018-2024)
Avg $29,058/year across 7 years
Top 2% in PA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
203
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$165,115 (81.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,396 (13.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,897 (5.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$29,686
2023
$80,693
2022
$24,566
2021
$18,248
2020
$16,331
2019
$18,484
2018
$15,401
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$8,265
Regeneron Pharmaceuticals, Inc.
$7,489
Merck Sharp & Dohme LLC
$6,046
Apellis Pharmaceuticals, Inc.
$5,155
Boehringer Ingelheim International GmbH
$1,477
ABBVIE INC.
$581
Regeneron Healthcare Solutions, Inc.
$470
Boston Scientific Corporation
$121
Ocular Therapeutix, Inc.
$42
Alcon Vision LLC
$22
Alimera Sciences, Inc.
$18
Top 3 companies account for 73.4% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb Americas Inc.
$33,093
Apellis Pharmaceuticals, Inc.
$29,979
Bausch & Lomb, a division of Bausch Health US, LLC
$26,865
Merck Sharp & Dohme Corporation
$23,201
Hoffmann-La Roche Limited
$21,756
Merck Sharp & Dohme LLC
$21,508
Regeneron Pharmaceuticals, Inc.
$17,590
Boehringer Ingelheim International GmbH
$8,872
Janssen Research & Development, LLC
$5,802
Allergan Inc.
$4,264
Allergan, Inc.
$3,426
F. Hoffmann-La Roche AG
$3,122
EyePoint Pharmaceuticals US, Inc.
$1,914
ABBVIE INC.
$969
Regeneron Healthcare Solutions, Inc.
$470
Boston Scientific Corporation
$121
Genentech USA, Inc.
$87
Astellas Pharma US Inc
$82
Genentech, Inc.
$76
Carl Zeiss Meditec, Inc.
$70
Ocular Therapeutix, Inc.
$42
Carl Zeiss Meditec AG
$39
Alcon Vision LLC
$22
NEW WORLD MEDICAL,INC.
$22
Alimera Sciences, Inc.
$18
Top 3 companies account for 44.2% of all-time payments
Associated products mentioned in payments ›
Ahmed Glaucoma Valve · Bausch + Lomb · Clareon · DEXTENZA · DEXYCU · EYLEA · EYLEA HD · LOTEMAX SM · Lucentis · MIEBO · None Specified · OPHTHALMIC INSTRUMENTS · OZURDEX · PROLENSA · RETISERT · STELLARIS · STELLARIS ELITE · STELLARIS PC · SURGICAL MISC · SUSVIMO · SYFOVRE · Stellaris · Syfovre · VISUDYNE · VITESSE · VYZULTA · Vabysmo · WaveWriter Alpha Prime 16 · XIPERE · YUTIQ · enVista MX60 IOL
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (81%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for ophthalmology in PA.
Geographic Context
Ophthalmologists within 10 mi
507
Per 100K population
58.9
County median income
$111,521
Nearest hospital
SUBURBAN COMMUNITY HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Garg is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with consulting-driven industry engagement in the top 2% of PA peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Garg experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Garg performed 23,160 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Garg receive payments from pharmaceutical companies?
Yes. Dr. Garg received a total of $203,408 from 25 companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garg's costs compare to other ophthalmologists in Plymouth Meeting?
Dr. Garg's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Ophthalmologists in Plymouth Meeting
Browse ophthalmologists in Plymouth Meeting ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in PA
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in PA
Which PA ophthalmologists receive the most from drug and device companies.
By company
Bausch & Lomb Americas Inc. Payments to Doctors
See all physicians who received payments from Bausch & Lomb Americas Inc.
By company
Apellis Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Apellis Pharmaceuticals, Inc.
By company
Bausch & Lomb, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Bausch & Lomb, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology